These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26871405)

  • 21. bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.
    Wooters TE; Smith AM; Pivavarchyk M; Siripurapu KB; McIntosh JM; Zhang Z; Crooks PA; Bardo MT; Dwoskin LP
    Br J Pharmacol; 2011 May; 163(2):346-57. PubMed ID: 21232049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats.
    Freitas K; Carroll FI; Negus SS
    Exp Clin Psychopharmacol; 2016 Feb; 24(1):65-75. PubMed ID: 26461167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term oral nicotine to monkeys.
    McCallum SE; Parameswaran N; Bordia T; Fan H; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2006 Jul; 318(1):381-8. PubMed ID: 16622038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nornicotine inhibition of dopamine transporter function in striatum via nicotinic receptor activation.
    Middleton LS; Crooks PA; Wedlund PJ; Cass WA; Dwoskin LP
    Synapse; 2007 Mar; 61(3):157-65. PubMed ID: 17146768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
    Maurer JJ; Sandager-Nielsen K; Schmidt HD
    Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged nicotine exposure down-regulates presynaptic NMDA receptors in dopaminergic terminals of the rat nucleus accumbens.
    Salamone A; Zappettini S; Grilli M; Olivero G; Agostinho P; Tomé AR; Chen J; Pittaluga A; Cunha RA; Marchi M
    Neuropharmacology; 2014 Apr; 79():488-97. PubMed ID: 24373903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.
    Sumithran SP; Crooks PA; Xu R; Zhu J; Deaciuc AG; Wilkins LH; Dwoskin LP
    AAPS J; 2005 Aug; 7(1):E201-17. PubMed ID: 16146341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.
    Cohen C; Bergis OE; Galli F; Lochead AW; Jegham S; Biton B; Leonardon J; Avenet P; Sgard F; Besnard F; Graham D; Coste A; Oblin A; Curet O; Voltz C; Gardes A; Caille D; Perrault G; George P; Soubrie P; Scatton B
    J Pharmacol Exp Ther; 2003 Jul; 306(1):407-20. PubMed ID: 12682217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α4β2 Nicotinic receptor desensitizing compounds can decrease self-administration of cocaine and methamphetamine in rats.
    Levin ED; Rezvani AH; Wells C; Slade S; Yenugonda VM; Liu Y; Brown ML; Xiao Y; Kellar KJ
    Eur J Pharmacol; 2019 Feb; 845():1-7. PubMed ID: 30529197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of bupropion on nicotine self-administration in rats.
    Rauhut AS; Neugebauer N; Dwoskin LP; Bardo MT
    Psychopharmacology (Berl); 2003 Aug; 169(1):1-9. PubMed ID: 12811464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
    Mugnaini M; Garzotti M; Sartori I; Pilla M; Repeto P; Heidbreder CA; Tessari M
    Neuroscience; 2006; 137(2):565-72. PubMed ID: 16289885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release.
    Grilli M; Parodi M; Raiteri M; Marchi M
    J Neurochem; 2005 Jun; 93(5):1353-60. PubMed ID: 15934954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.
    Bordia T; McGregor M; Papke RL; Decker MW; McIntosh JM; Quik M
    Exp Neurol; 2015 Jan; 263():277-84. PubMed ID: 25261754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
    Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
    Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential region-specific regulation of α4β2* nAChRs by self-administered and non-contingent nicotine in C57BL/6J mice.
    Metaxas A; Bailey A; Barbano MF; Galeote L; Maldonado R; Kitchen I
    Addict Biol; 2010 Oct; 15(4):464-79. PubMed ID: 20731631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α6β2 subunit containing nicotinic acetylcholine receptors exert opposing actions on rapid dopamine signaling in the nucleus accumbens of rats with high-versus low-response to novelty.
    Siciliano CA; McIntosh JM; Jones SR; Ferris MJ
    Neuropharmacology; 2017 Nov; 126():281-291. PubMed ID: 28666811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization.
    Bordia T; Campos C; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2010 Jun; 333(3):929-38. PubMed ID: 20200117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term nicotine exposure depresses dopamine release in nonhuman primate nucleus accumbens.
    Perez XA; Ly J; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):335-44. PubMed ID: 22562772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic nicotine treatment attenuates alpha 7 nicotinic receptor deficits following traumatic brain injury.
    Verbois SL; Scheff SW; Pauly JR
    Neuropharmacology; 2003 Feb; 44(2):224-33. PubMed ID: 12623221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.